On April 22, 2021, a District Judge in the United States District Court for the Western District of Texas ruled that the motion to dismiss the class action lawsuit against Zachry Holdings, Inc. (โZachryโ), Chief Executive Officer of Zachry, the Compensation and Benefits Committee of Zachry (โCommitteeโ), and Does 1-20 (collectively, โDefendantsโ) was denied, allowing Plaintiffs' claims to proceed. Zachry offers the ZHI 401(k) Retirement Savings Plan (โthe Planโ), a…
On March 31, 2021, a district judge for the United States District Court for the Western District of North Carolina determined that a class action lawsuit against Coca-Cola Consolidated, Inc., and its Corporate Benefits Committee (collectively, โCoke Bottling,โ the โCompany,โ or โDefendantsโ), was fit to proceed, denying the Companyโs attempt to dismiss the legal action. The lawsuit stems from allegations that the Company mismanaged its defined contribution retirement plan (the…
On March 25, 2021, the United States District Court for the Central District of California determined that a class action lawsuit against American Honda Motors, Inc. (โHondaโ or the "Company") was fit to proceed, denying Hondaโs attempt to dismiss the legal action. Plaintiffs, represented by Miller Shah LLP, allege that certain of Hondaโs model Acura MDX from years 2016 to 2020 and model Acura RDX from years 2019 to 2020…
On March 23, 2021, a District Judge in the United States District Court for the Northern District of California granted Plaintiffsโ Motion for Class Certification in an action against American Honda Motors, Inc. (โHondaโ), denying Hondaโs Motion to Strike Expert Testimony in the process. In 2016, Plaintiffs filed a lawsuit alleging that Honda failed to disclose a defect in the โhands freeโ calling system, HandsFreeLinkโข (โHFLโ), featured in the 2004…
On July 1, 2020, the Department of Justice (โDOJโ) announced that Novartis Pharmaceutical Corporation (โNovartisโ), a New Jersey-based pharmaceutical company, agreed to pay over $642 million in separate to resolve alleged violation of the False Claims Act (โFCAโ), 31 U.S.C. ยงยง 3729โ3733. The settlement resolves allegations that Novartis made improperly payments to Medicare patients and prescribing physicians to promote Novartis's drugs, Gilenya and Afinitor. The FCA allows private citizens (known…
On January 6, 2020, Teva Pharmaceuticals agreed to a $54 million settlement to resolve a False Claims Act action brought against Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., and Teva Sales and Marketing, Inc. (collectively โTevaโ). The settlement resolves allegations that Teva violated the False Claims Act and the Anti-Kickback Statute by using speaker events to bribe doctors to prescribe two of its drugs, Copaxone and Azilect. The False Claims…
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
CT Chester | 866-540-5505
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Francisco | 866-540-5505
FL Fort Lauderdale | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CA Los Angeles | 866-540-5505
CA Los Angeles | 866-540-5505
CT Chester | 866-540-5505
CT Chester | 866-540-5505
FL Fort Lauderdale | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Diego | 866-540-5505
PA Philadelphia | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
CA San Diego | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
FL Fort Lauderdale | 866-540-5505
NJ Hoboken | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
IT Milan | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Francisco | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
CT Chester | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Diego | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
CA Los Angeles | 310-203-0600